Valuation Clinuvel Pharmaceuticals Limited

Stocks

Market Closed - Australian S.E. 10:40:30 27/10/2026 am IST			5-day change	1st Jan Change
7.200 ^AUD	+2.71%		-3.75%	-42.38%

19/10	Disc Medicine's late-stage win clears path for approval of sun-allergy pill	RE
01/10	Clinuvel Pharmaceuticals Ltd Presents New Patient Cases Demonstrating Clinical Response To SCENESSE With Adjunct Narrowband Ultraviolet B Phototherapy In Vitiligo Patients To EADV	CI

Data adjusted to current consolidation scope

Fiscal Period: June	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	733.7	883.5	769.8	520.3	518.4	353.5	-	-
Change	-	20.4%	-12.87%	-32.41%	-0.36%	-31.81%	-	-
Enterprise Value (EV) ¹	612.2	726.6	585.9	296.2	309.1	70.39	37.88	0.3926
Change	-	18.69%	-19.37%	-49.45%	4.37%	-77.23%	-46.19%	-98.96%
P/E	36.8x	30.3x	22x	14.5x	15.4x	10.2x	9.79x	6.87x
PBR	5.84x	5.37x	3.79x	2.17x	1.91x	1.16x	1.05x	0.91x
PEG	-	0.6x	1.2x	5.06x	-2.21x	3.07x	2.6x	0.2x
Capitalization / Revenue	11.2x	11.3x	8.73x	5.48x	5.51x	3.74x	3.52x	2.63x
EV / Revenue	9.32x	9.28x	6.64x	3.12x	3.29x	0.75x	0.38x	0x
EV / EBITDA	16.4x	19.5x	12x	6.84x	8.09x	1.86x	0.96x	0.01x
EV / EBIT	16.7x	20x	12.3x	7.03x	8.31x	1.92x	0.99x	0.01x
EV / FCF	15.5x	20.2x	18.6x	7.26x	8.76x	1.92x	0.94x	0.01x
FCF Yield	6.44%	4.94%	5.37%	13.8%	11.4%	52%	106%	14,226%
Dividend per Share ²	0.04	0.05	0.05	0.05	0.05	0.0547	0.0592	0.0832
Rate of return	0.27%	0.28%	0.33%	0.48%	0.49%	0.78%	0.84%	1.19%
EPS ²	0.403	0.591	0.698	0.718	0.668	0.6902	0.7162	1.021
Distribution rate	9.93%	8.46%	7.16%	6.96%	7.49%	7.92%	8.26%	8.15%
Net sales ¹	65.72	78.32	88.18	95.02	94.02	94.47	100.4	134.4
EBITDA ¹	37.44	37.2	48.95	43.3	38.2	37.75	39.3	57.96
EBIT ¹	36.68	36.41	47.81	42.12	37.21	36.65	38.13	56.47
Net income ¹	20.88	30.6	35.64	36.17	33.92	34.94	36.32	51.72
Net Debt ¹	-121.5	-156.8	-183.9	-224.1	-209.3	-283.1	-315.6	-353.1
Reference price ²	14.850	17.880	15.370	10.380	10.280	7.010	7.010	7.010
Nbr of stocks (in thousands)	49,410	49,410	50,083	50,124	50,428	50,428	-	-
Announcement Date	30/08/22	29/08/23	28/08/24	27/08/25	27/08/26	-	-	-

¹AUD in Million²AUD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
CLINUVEL PHARMACEUTICALS LIMITED	10.32x	0.8x	2.01x	0.77%	25Cr
ELI LILLY AND COMPANY	37.06x	13.1x	27.8x	0.54%	1,13500Cr
JOHNSON & JOHNSON	38.61x	6.49x	18.27x	2.02%	64TCr
ABBVIE INC.	36.46x	8.38x	17.33x	2.41%	50TCr
ROCHE HOLDING AG	20.87x	5.11x	12.73x	2.56%	38TCr
MERCK & CO., INC.	105.89x	5.92x	25.41x	2.34%	36TCr
NOVARTIS AG	21.76x	5.68x	13.94x	2.81%	29TCr
ASTRAZENECA PLC	22.43x	4.53x	12.94x	1.95%	27TCr
AMGEN INC.	27.87x	7.16x	12.81x	2.3%	24TCr
GILEAD SCIENCES, INC.	-45.48x	6.98x	27.06x	2.11%	19TCr
Average	27.58x	6.41x	17.03x	1.98%	40.04TCr
Weighted average by Cap.	35.23x	8.29x	20.39x	1.8%